Brief Reports
Vol. 2 No. 1 (2023)
Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 24 August 2022
Accepted: 18 January 2023
Accepted: 18 January 2023
1415
Views
278
Downloads
Authors
Adenosine diphosphate (ADP) receptors and protein-kinase C (PKC) isoforms play different role in platelet activity. In the present study, whole blood platelet adhesion at 200 - 1800 s-1 shear rates was investigated by Impact-R system, measuring percent of surface coverage (SC) by platelets. Gradual heightened shear rate par-alleled increase of platelet adhesion. At relatively low shear (200 and 1000 s-1) blockade of neither P2Y1 receptor nor P2Y12 receptor (by A2P5P and 2MeSAMP, respectively) affected SC. At high shear rate (1800 s-1) reduction of SC was observed by 2MeSAMP. Treatment of blood with PKCδ inhibitor (rottlerin) but not PKCα,β inhibitor (Gö6976) diminished platelet adhe-sion. Among all the agents, only combination of 2MeSAMP and rottlerin used at subthreshold concentrations was able to inhibit platelet adhesion under high shear condition. We suggest that platelet agonist-induced P2Y12 and PKCδ signaling essentially stimulates platelet adhesion under flow condition, the important initiating step of thrombin formation.
Downloads
Download data is not yet available.
Citations
Burnstock G. Blood cells an historical account of the roles of purinergic signaling. Purinergic Signal 2015:11;411-4. DOI: https://doi.org/10.1007/s11302-015-9462-7
Yanachkov IB, Chang H, Yanachkova MI, et al. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors. Europ J Med Chem 2016;107:204-8. DOI: https://doi.org/10.1016/j.ejmech.2015.10.055
Hechler B, Léon C, Vial C, et al. The P2Y1 receptor is neces-sary for adenosine 5′-diphosphate-induced platelet aggrega-tion. Blood 1998;92:152-9. DOI: https://doi.org/10.1182/blood.V92.1.152.413k27_152_159
Kunapuli SP, Dorsam RT, Kim S, et al. Platelet purinergic re-ceptors. Curr Opin Pharmacol 2003;3:175–80. DOI: https://doi.org/10.1016/S1471-4892(03)00007-9
Oliphant CS, Doby J B, Blade CL, et al. Emerging P2Y12 re-ceptor antagonists: role in coronary artery disease. Curr Vasc Pharmacol 2010;8:93-101. DOI: https://doi.org/10.2174/157016110790226615
Machal J, Hinomaz O. Efficacy of P2Y12 receptor blockers after myocardial infarction and genetic variability of their metabolic pathways. Curr Vasc Pharmacol 2019;17:35-40. DOI: https://doi.org/10.2174/1570161116666180206110657
Mellor H, Parker PJ. The extented protein kinase C superfam-ily. Biochem J 1998;332;281-92. DOI: https://doi.org/10.1042/bj3320281
Harper MT, Poole AW. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 2010;8:454-62. DOI: https://doi.org/10.1111/j.1538-7836.2009.03722.x
Unsworth AJ, Smith H, Gissen P, et al. Submaximal inhibition of protein kinase C restores ADP-induced dense granule se-cretion in platelets in the presence of Ca2+. J Biol Chem 2011;286:21073-82. DOI: https://doi.org/10.1074/jbc.M110.187138
Mundell SJ, Jones ML, Hardy AR, et al. Distinct roles for pro-tein kinase C isoforms in regulating platelet purinergic recep-tor function. Mol Pharmacol 2006;70:1132-42. DOI: https://doi.org/10.1124/mol.106.023549
Xiang B, Zhang G, Ren H, et al. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism. PLoS One 2012;7; e51037. DOI: https://doi.org/10.1371/journal.pone.0051037
Koivunen J, Aaltonen V, Koskela S, et al. Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junc-tions and inhibitors invasion of urinary bladder carcinoma cells. Cancer Res 2005;64:5693-701. DOI: https://doi.org/10.1158/0008-5472.CAN-03-3511
Bong KA, Se KJ, Hee SK, et al. Rottlerin, a specific inhibitor of protein kinase C-delta, impedes barrier repair response by increasing intracellular free calcium. J Invest Dermatol 2006;126:1348-55. DOI: https://doi.org/10.1038/sj.jid.5700244
Lee TH, Chen JL, Liu PS, et al. Rottlerin, a natural polyphenol compound, inhibits upregulation of matrix metalloproteinase-9 and brain astrocytic migration by reducing PKC-δ-depen-dent ROS signal. J Neuroinflammation 2020;17:177. DOI: https://doi.org/10.1186/s12974-020-01859-5
Pham VT, Joo JE, YS, et al. A concise synthesis of a promis-ing protein kinase C inhibitor: D-erythro-sphingosine. Arch Pharmacol Res 2007;30:22-7. DOI: https://doi.org/10.1007/BF02977774
Shenkman B, Einav Y, Salomon O, et al. Testing agonist-in-duced platelet aggregation by the Impact-R [Cone and Plate(let) analyzer (CPA)]. Platelet 2008;19:440-6. DOI: https://doi.org/10.1080/09537100802082256
Zhang M, Wu Y, Hauch K, Horbett TA. Fibrinogen and von Willebrand factor mediated platelet adhesion to polystyrene under flow conditions. J Biomater Sci Polym 2008;19: 1383-410. DOI: https://doi.org/10.1163/156856208786052353
Ramstrom S, Ranby M, Lindahl TL. Effects of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fib-rinolysis resistance studied with free oscillation rheometry. Thromb Res 2003;109:315-22. DOI: https://doi.org/10.1016/S0049-3848(03)00254-8
Turner NA, Moake JL, McIntire LV. Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood 2001;98:3340-5. DOI: https://doi.org/10.1182/blood.V98.12.3340
Yacoub D, Theoret JF, Villneuve L, et al. Essential role of pro-tein kinase C delta in platelet signaling, alpha IIB beta 3 acti-vation, and thromboxane A2 release. J Biol Chem 2006;281: 30024-35. DOI: https://doi.org/10.1074/jbc.M604504200
How to Cite
1.
Shenkman B, Budnik I, Einav Y. Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition . Bleeding Thromb Vascul Biol [Internet]. 2023 Feb. 16 [cited 2025 Nov. 24];2(1). Available from: https://www.btvb.org/btvb/article/view/51
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- Roger Lijnen, Désiré Collen, The key to fibrinolysis and thrombolysis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- CO43 | Early platelet dysfunction in sepsis: an ICU pilot study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO09 | Comparison of different aggregometry methods for evaluation of platelet function in patients with myeloproliferative neoplasms , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Giovanni de Gaetano, When a feminist platelet went to the convention of prostaglandins and thromboxanes , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- PO01 | Diagnosis of inherited platelet function disorders by platelet aggregometry using a fully automated coagulation analyzer , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO46 | Comparison of reticulated platelet procoagulant role in liver cirrhosis vs. fibrosis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO58 | Gender differences in primary haemostasis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Marco Cattaneo, Claudia Ghali, Mariangela Scavone, ReDIP, the Italian network for the diagnosis of congenital platelet function disorders , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 1 (2024)
- Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele, A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 2 (2022)
- Francesca Santilli, Paola Simeone, Rossella Liani, Inflammation, platelets and diabetes , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
1-10 of 84
Next
You may also start an advanced similarity search for this article.